Reviews Theophylline in 5% Dextrose Injection Excel Container


No reviews yet.

Theophylline in 5% Dextrose Injection Excel Container Drug Description
Theophylline in 5% Dextrose Injections USP
Excel Container
Do not admix with other drugs.
DRUG DESCRIPTION
Theophylline in 5% Dextrose Injections USP are sterile, nonpyrogenic solutions
intended for intravenous administration, prepared from theophylline and dextrose
in Water for Injection USP.
Composition - Each 100 mL contains



Solution
Anhydrous Theophylline USP
Hydrous Dextrose USP
pH
Calculated Osmolarity mOsmol/liter


0.08% Theophylline in 5% Dextrose Injection USP
80 mg
5 g
4.7 (3.5-6.5)
255


0.16% Theophylline in 5% Dextrose Injection USP
160 mg
5 g
4.7 (3.5-6.5)
260



Water for Injection USP, qs
Theophylline is structurally classified as a methylxanthine. It occurs as a
white, odorless, crystalline powder with a bitter taste. Anhydrous theophylline
has the chemical name 1H-Purine-2, 6-dione, 3,7-dihydro-1, 3-dimethyl-, and
is represented by the following structural formula:
The formulas of the active ingredients are:







Theophylline, Anhydrous, USP







Hydrous Dextrose USP
The molecular formula of anhydrous theophylline is C7H8N4O2
with a molecular weight of 180.17. The molecular formula of hydrous dextrose
is C6H12O6•H2O with a molecular
weight of 198.17.
The EXCEL Container is Latex-free; PVC-free; and DEHP-free.
The plastic container is made from a multilayered film specifically developed
for parenteral drugs. It contains no plasticizers and exhibits virtually no
leachables. The solution contact layer is a rubberized copolymer of ethylene
and propylene. The container is nontoxic and biologically inert. The container-solution
unit is a closed system and is not dependent upon entry of external air during
administration. The container is overwrapped to provide protection from the
physical environment and to provide an additional moisture barrier when necessary.
The closure system has two ports; the one for the administration set has a
tamper evident plastic protector. Refer to the Directions for Use of the container.Last reviewed on RxList: 8/28/2008




Theophylline in 5% Dextrose Injection Excel Container Drug Description
Theophylline in 5% Dextrose Injections USP
Excel Container
Do not admix with other drugs.
DRUG DESCRIPTION
Theophylline in 5% Dextrose Injections USP are sterile, nonpyrogenic solutions
intended for intravenous administration, prepared from theophylline and dextrose
in Water for Injection USP.
Composition - Each 100 mL contains



Solution
Anhydrous Theophylline USP
Hydrous Dextrose USP
pH
Calculated Osmolarity mOsmol/liter


0.08% Theophylline in 5% Dextrose Injection USP
80 mg
5 g
4.7 (3.5-6.5)
255


0.16% Theophylline in 5% Dextrose Injection USP
160 mg
5 g
4.7 (3.5-6.5)
260



Water for Injection USP, qs
Theophylline is structurally classified as a methylxanthine. It occurs as a
white, odorless, crystalline powder with a bitter taste. Anhydrous theophylline
has the chemical name 1H-Purine-2, 6-dione, 3,7-dihydro-1, 3-dimethyl-, and
is represented by the following structural formula:
The formulas of the active ingredients are:







Theophylline, Anhydrous, USP







Hydrous Dextrose USP
The molecular formula of anhydrous theophylline is C7H8N4O2
with a molecular weight of 180.17. The molecular formula of hydrous dextrose
is C6H12O6•H2O with a molecular
weight of 198.17.
The EXCEL Container is Latex-free; PVC-free; and DEHP-free.
The plastic container is made from a multilayered film specifically developed
for parenteral drugs. It contains no plasticizers and exhibits virtually no
leachables. The solution contact layer is a rubberized copolymer of ethylene
and propylene. The container is nontoxic and biologically inert. The container-solution
unit is a closed system and is not dependent upon entry of external air during
administration. The container is overwrapped to provide protection from the
physical environment and to provide an additional moisture barrier when necessary.
The closure system has two ports; the one for the administration set has a
tamper evident plastic protector. Refer to the Directions for Use of the container.Last reviewed on RxList: 8/28/2008




Theophylline in 5% Dextrose Injection Excel Container Drug Description
Theophylline in 5% Dextrose Injections USP
Excel Container
Do not admix with other drugs.
DRUG DESCRIPTION
Theophylline in 5% Dextrose Injections USP are sterile, nonpyrogenic solutions
intended for intravenous administration, prepared from theophylline and dextrose
in Water for Injection USP.
Composition - Each 100 mL contains



Solution
Anhydrous Theophylline USP
Hydrous Dextrose USP
pH
Calculated Osmolarity mOsmol/liter


0.08% Theophylline in 5% Dextrose Injection USP
80 mg
5 g
4.7 (3.5-6.5)
255


0.16% Theophylline in 5% Dextrose Injection USP
160 mg
5 g
4.7 (3.5-6.5)
260



Water for Injection USP, qs
Theophylline is structurally classified as a methylxanthine. It occurs as a
white, odorless, crystalline powder with a bitter taste. Anhydrous theophylline
has the chemical name 1H-Purine-2, 6-dione, 3,7-dihydro-1, 3-dimethyl-, and
is represented by the following structural formula:
The formulas of the active ingredients are:







Theophylline, Anhydrous, USP







Hydrous Dextrose USP
The molecular formula of anhydrous theophylline is C7H8N4O2
with a molecular weight of 180.17. The molecular formula of hydrous dextrose
is C6H12O6•H2O with a molecular
weight of 198.17.
The EXCEL Container is Latex-free; PVC-free; and DEHP-free.
The plastic container is made from a multilayered film specifically developed
for parenteral drugs. It contains no plasticizers and exhibits virtually no
leachables. The solution contact layer is a rubberized copolymer of ethylene
and propylene. The container is nontoxic and biologically inert. The container-solution
unit is a closed system and is not dependent upon entry of external air during
administration. The container is overwrapped to provide protection from the
physical environment and to provide an additional moisture barrier when necessary.
The closure system has two ports; the one for the administration set has a
tamper evident plastic protector. Refer to the Directions for Use of the container.Last reviewed on RxList: 8/28/2008




Theophylline in 5% Dextrose Injection Excel Container Drug Description
Theophylline in 5% Dextrose Injections USP
Excel Container
Do not admix with other drugs.
DRUG DESCRIPTION
Theophylline in 5% Dextrose Injections USP are sterile, nonpyrogenic solutions
intended for intravenous administration, prepared from theophylline and dextrose
in Water for Injection USP.
Composition - Each 100 mL contains



Solution
Anhydrous Theophylline USP
Hydrous Dextrose USP
pH
Calculated Osmolarity mOsmol/liter


0.08% Theophylline in 5% Dextrose Injection USP
80 mg
5 g
4.7 (3.5-6.5)
255


0.16% Theophylline in 5% Dextrose Injection USP
160 mg
5 g
4.7 (3.5-6.5)
260



Water for Injection USP, qs
Theophylline is structurally classified as a methylxanthine. It occurs as a
white, odorless, crystalline powder with a bitter taste. Anhydrous theophylline
has the chemical name 1H-Purine-2, 6-dione, 3,7-dihydro-1, 3-dimethyl-, and
is represented by the following structural formula:
The formulas of the active ingredients are:







Theophylline, Anhydrous, USP







Hydrous Dextrose USP
The molecular formula of anhydrous theophylline is C7H8N4O2
with a molecular weight of 180.17. The molecular formula of hydrous dextrose
is C6H12O6•H2O with a molecular
weight of 198.17.
The EXCEL Container is Latex-free; PVC-free; and DEHP-free.
The plastic container is made from a multilayered film specifically developed
for parenteral drugs. It contains no plasticizers and exhibits virtually no
leachables. The solution contact layer is a rubberized copolymer of ethylene
and propylene. The container is nontoxic and biologically inert. The container-solution
unit is a closed system and is not dependent upon entry of external air during
administration. The container is overwrapped to provide protection from the
physical environment and to provide an additional moisture barrier when necessary.
The closure system has two ports; the one for the administration set has a
tamper evident plastic protector. Refer to the Directions for Use of the container.Last reviewed on RxList: 8/28/2008




Theophylline in 5% Dextrose Injection Excel Container Drug Description
Theophylline in 5% Dextrose Injections USP
Excel Container
Do not admix with other drugs.
DRUG DESCRIPTION
Theophylline in 5% Dextrose Injections USP are sterile, nonpyrogenic solutions
intended for intravenous administration, prepared from theophylline and dextrose
in Water for Injection USP.
Composition - Each 100 mL contains



Solution
Anhydrous Theophylline USP
Hydrous Dextrose USP
pH
Calculated Osmolarity mOsmol/liter


0.08% Theophylline in 5% Dextrose Injection USP
80 mg
5 g
4.7 (3.5-6.5)
255


0.16% Theophylline in 5% Dextrose Injection USP
160 mg
5 g
4.7 (3.5-6.5)
260



Water for Injection USP, qs
Theophylline is structurally classified as a methylxanthine. It occurs as a
white, odorless, crystalline powder with a bitter taste. Anhydrous theophylline
has the chemical name 1H-Purine-2, 6-dione, 3,7-dihydro-1, 3-dimethyl-, and
is represented by the following structural formula:
The formulas of the active ingredients are:







Theophylline, Anhydrous, USP







Hydrous Dextrose USP
The molecular formula of anhydrous theophylline is C7H8N4O2
with a molecular weight of 180.17. The molecular formula of hydrous dextrose
is C6H12O6•H2O with a molecular
weight of 198.17.
The EXCEL Container is Latex-free; PVC-free; and DEHP-free.
The plastic container is made from a multilayered film specifically developed
for parenteral drugs. It contains no plasticizers and exhibits virtually no
leachables. The solution contact layer is a rubberized copolymer of ethylene
and propylene. The container is nontoxic and biologically inert. The container-solution
unit is a closed system and is not dependent upon entry of external air during
administration. The container is overwrapped to provide protection from the
physical environment and to provide an additional moisture barrier when necessary.
The closure system has two ports; the one for the administration set has a
tamper evident plastic protector. Refer to the Directions for Use of the container.Last reviewed on RxList: 8/28/2008





Other reviews about Theophylline in 5% Dextrose Injection Excel Container on wordpress

SayIm a bear at multiplyin by ten.
  by trghlngatzqh
Then he stood upright while Hans drew the rope taut across the overhead branch. It is well known how the monks wrote silly lives of Catholic Saints over […]


Between the grip and the ho
  by xuxmbduwnlcbk
David Grief caught a swift vision of an alcoholic degenerate putting a very loving young couple to death with a copper spike, for a copper spike was what […]


, by which time the te
  by yqipbxqcsbsrx
It was a glistening, whiteandblue day. One was into the Socialist Party; the other was into the Republican Party. We must make sure of the newcomers. But the […]


He felt sure that she
  by wxwkhnwzrbfb
But she had an obsession about the police and their doings. An embarrassing and unwarranted invasion of a mans last protecting stronghold, his own mind. In a few […]


I could put up for a room in t
  by fghyswdblbhr
He made all, Thorn for the camel, fodder for the kine, And mothers heart for sleepy head, O little son […]



Other reviews about Theophylline in 5% Dextrose Injection Excel Container on web:

Learn about the prescription medication Theophylline in 5% Dextrose Injection Excel Container (Theophylline in Dextrose Excel Container), drug uses, dosage, side effects, drug ... Theophylline in 5% Dextrose Injection Excel Container ...


Learn about the prescription medication Theophylline in 5% Dextrose Injection Flexible Plastic Container (Theophylline in 5% Dextrose Injection Flexible Plastic Container), drug ... Theophylline in 5% Dextrose Injection Flexible Plastic Container ...


07-19-38-358 Theophylline in 5% Dextrose Injection, USP in Plastic Container VIAFLEXPlus Container ·· BAR CODE POSITION ONLY 071938358 Description Theophylline in 5% Dextrose Injection ... Theophylline in 5% Dextrose Injection, USP in Plastic Container


Theophylline in 5% Dextrose Injections USP are indicated as an ... Theophylline in 5% Dextrose Injections USP are supplied sterile and nonpyrogenic in EXCEL ® Containers. Theophylline Injection - Indications and Dosage


-----THEOPHYLLINE IN DEXTROSE -theophylline injection, solution Hospira, Inc. THEOPHYLLINE 200, 400 AND 800 mg in 5% Dextrose Injection, USP Flexible Plastic Container Do not admix with ... Theophylline in 5% Dextrose Injection


Theophylline in 5% Dextrose injection, USP, Flexible Plastic Container March 2009 Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research ... Theophylline in 5% Dextrose injection, USP, Flexible Plastic ...


Theophylline In 5% Dextrose Injection, USP. In VIAFLEX container (Baxter) Premix medications are exempt from minimum order charge. Cardinal Health:Theophylline In 5% Dextrose Injection, USP


Theophylline in 5% Dextrose Injections USP are sterile, nonpyrogenic solutions intended for ... The EXCEL Container is Latex-free; PVC-free; and DEHP-free. The plastic ... Theophylline Injection - Description and Clinical Pharmacology


Theophylline in 5% Dextrose Injection Excel Container: Theophylline in Dextrose Excel Container: Theophylline in 5% Dextrose Injection Flexible Plastic Container Vademecum de Argentina - Vademecum USA 2009 - T


Theophylline in 5% Dextrose Injection Excel Container (Theophylline in Dextrose Excel Container) Theophylline in 5% Dextrose Injection Flexible Plastic Container (Theophylline in 5 ... Drugs A-Z List - T on RxList





Featured Reviews

Reviews Halog Solution

Halog Solution Drug Description HALOG® SOLUTION (halcinonide) Topical Solution, USP 0.1% For Topical Use Only. Not For Ophthalmic Use. DRUG DESCRIPTION What are the possible side effects of halcinonide topical (Halog,...
Read More  |  Review This
Reviews Abacavir Sulfate and Lamivudine Tablets

Epzicom Drug Description EPZICOM® (abacavir sulfate and lamivudine) Tablets WARNINGS EPZICOM contains 2 nucleoside analogues (abacavir sulfate and lamivudine) and is intended only for patients whose regimen would otherwise include...
Read More  |  Review This
Reviews Lac-Hydrin

Lac-Hydrin Drug Description Lac-Hydrin® (ammonium lactate) Lotion, 12% For Dermatologic use only. Not for Ophthalmic, Oral or Intravaginal use. DRUG DESCRIPTION Lac-Hydrin specially formulates 12% lactic acid, neutralized with...
Read More  |  Review This
Reviews Erythromycin Delayed Release Tablets

Ery-Tab Drug Description ERY-TAB® (erythromycin) Delayed-Release Tablets, USP Enteric-Coated To reduce the development of drug-resistant bacteria and maintain the effectiveness of ERY-TAB and other antibacterial drugs, ERY-TAB...
Read More  |  Review This
Reviews Metadate ER

Metadate ER Drug Description METADATE ER (methylphenidate hydrochloride) Tablet Extended Release DRUG DESCRIPTION What are the possible side effects of methylphenidate? Get emergency medical help if you have any of these signs...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....